These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22947694)

  • 1. Central dopaminergic activity influences metabolic parameters in healthy men.
    Brunerova L; Potockova J; Horacek J; Suchy J; Andel M
    Neuroendocrinology; 2013; 97(2):132-8. PubMed ID: 22947694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women--a preliminary study.
    Craig MC; Cutter WJ; Wickham H; van Amelsvoort TA; Rymer J; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2004 Nov; 29(10):1309-16. PubMed ID: 15288710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.
    Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC
    Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual apomorphine as a neuroendocrine probe.
    Brunerova L; Potockova J; Horacek J; Koprivova H; Rehula M; Andel M
    Psychiatry Res; 2012 Jul; 198(2):297-9. PubMed ID: 22394588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
    Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
    Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
    dos Santos Silva CM; Barbosa FR; Lima GA; Warszawski L; Fontes R; Domingues RC; Gadelha MR
    Obesity (Silver Spring); 2011 Apr; 19(4):800-5. PubMed ID: 20559294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK; Jain SK
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin - growth hormone releasing and orexigenic hormone in men declines with age, insulin and with decrease in testosterone concentration.
    Kozakowski J; Rabijewski M; Zgliczyński W
    Neuro Endocrinol Lett; 2008 Feb; 29(1):100-6. PubMed ID: 18283260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
    Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
    Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.